REALIXIA
How Biopharma Innovation Is Driving Demand for Large Molecules Drug Substance CDMO Services in the US
The Large Molecules Drug Substance CDMO Market is expanding as pharmaceutical and biotechnology companies increasingly outsource the development and manufacturing of complex biological drug substances to specialized contract development and manufacturing organizations. Large-molecule drug substances include biologics such as monoclonal antibodies, recombinant proteins, vaccines, and other...
1.4K Προβολές